Greater Nocturnal Blood Pressure Is Associated With Natriuretic Peptide Level in Aortic Stenosis With Preserved Ejection Fraction.

BACKGROUND Although careful monitoring of asymptomatic severe aortic stenosis (AS) is recommended to prevent missing the optimal timing of surgical or transcatheter aortic valve replacement, prophylactic treatment that could extend the asymptomatic period remains unknown. In a hypertensive population, high blood pressure (BP) measured at the doctor's office is known to be associated with B-type natriuretic peptide (BNP) level, a surrogate marker for symptomatic deterioration in AS. Little is known regarding the association between nocturnal BP variables and BNP in severe AS with preserved ejection fraction (EF). Methods and Results: The subjects consisted of 78 severe AS patients (mean age, 79±6 years) with preserved EF. Nocturnal BP was measured hourly using a home BP monitoring device. On multiple regression analysis, nocturnal mean systolic BP (SBP) remained independently associated with BNP after adjustment for age, sex, body mass index, estimated glomerular filtration rate, antihypertensive medication class, early diastolic mitral annular velocity, and left ventricular mass index (P=0.03), whereas diastolic BP (DBP) and variables of BP variability were not. CONCLUSIONS Higher nocturnal SBP rather than DBP or indices of BP variability was independently associated with BNP in AS patients with preserved EF. Intervention for nocturnal SBP may therefore extend the asymptomatic period and improve prognosis.

[1]  C. Izumi,et al.  Early Surgery vs. Surgery After Watchful Waiting for Asymptomatic Severe Aortic Stenosis. , 2018, Circulation journal : official journal of the Japanese Circulation Society.

[2]  Wilbert S Aronow,et al.  2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. , 2018, Hypertension.

[3]  Shigeru Tanaka,et al.  Comparison of Prognostic Values of Daytime and Night-Time Systolic Blood Pressures on Renal Outcomes in Patients With Chronic Kidney Disease. , 2017, Circulation journal : official journal of the Japanese Circulation Society.

[4]  J. Chambers,et al.  Recommendations on the Echocardiographic Assessment of Aortic Valve Stenosis: A Focused Update from the European Association of Cardiovascular Imaging and the American Society of Echocardiography. , 2017, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[5]  C. Izumi,et al.  Predictors of Rapid Progression and Clinical Outcome of Asymptomatic Severe Aortic Stenosis. , 2016, Circulation journal : official journal of the Japanese Circulation Society.

[6]  K. Kario,et al.  Sleep Blood Pressure Self‐Measured at Home as a Novel Determinant of Organ Damage: Japan Morning Surge Home Blood Pressure (J‐HOP) Study , 2015, Journal of clinical hypertension.

[7]  Pang-Hu Zhou,et al.  Plasma concentrations of adrenomedullin and natriuretic peptides in patients with essential hypertension. , 2015, Experimental and therapeutic medicine.

[8]  Victor Mor-Avi,et al.  Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. , 2015, European heart journal cardiovascular Imaging.

[9]  Yutaka Imai,et al.  Added Predictive Value of Night-Time Blood Pressure Variability for Cardiovascular Events and Mortality: The Ambulatory Blood Pressure–International Study , 2014, Hypertension.

[10]  Thoralf M Sundt,et al.  2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. , 2014, Circulation.

[11]  M. Enriquez-Sarano,et al.  The global burden of aortic stenosis. , 2014, Progress in cardiovascular diseases.

[12]  T. Himoto,et al.  Analysis of association between brain natriuretic peptide levels and blood pressure variability , 2014, Experimental and therapeutic medicine.

[13]  N. Sattar,et al.  The Value of N-Terminal Pro–B-Type Natriuretic Peptide in Determining Antihypertensive Benefit: Observations From the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT) , 2014, Hypertension.

[14]  A. Peters,et al.  Long‐term pattern of brain natriuretic peptide and N‐terminal pro brain natriuretic peptide and its determinants in the general population: contribution of age, gender, and cardiac and extra‐cardiac factors , 2013, European journal of heart failure.

[15]  C. Lang,et al.  Improving the primary prevention of cardiovascular events by using biomarkers to identify individuals with silent heart disease. , 2012, Journal of the American College of Cardiology.

[16]  K. Kario,et al.  Nocturnal blood pressure and cardiovascular disease: a review of recent advances , 2012, Hypertension Research.

[17]  K. Kario,et al.  Association between asleep blood pressure and brain natriuretic peptide during antihypertensive treatment: the Japan Morning Surge-Target Organ Protection (J-TOP) study , 2012, Journal of hypertension.

[18]  R. Sacco,et al.  Relationship between ambulatory blood pressure and aortic arch atherosclerosis. , 2012, Atherosclerosis.

[19]  K. Kario,et al.  Association of home and ambulatory blood pressure changes with changes in cardiovascular biomarkers during antihypertensive treatment. , 2012, American journal of hypertension.

[20]  N. Girerd,et al.  N-Terminal Pro-Brain Natriuretic Peptide: A Powerful Predictor of Mortality in Hypertension , 2011, Hypertension.

[21]  J. Staessen,et al.  Predictive role of the nighttime blood pressure. , 2011, Hypertension.

[22]  S. Pocock,et al.  Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. , 2010, The New England journal of medicine.

[23]  J. Mariani,et al.  Hemodynamic Determinants of Myocardial B-Type Natriuretic Peptide Release: Relative Contributions of Systolic and Diastolic Wall Stress , 2010, Hypertension.

[24]  E. Staal,et al.  Impact of hypertension on left ventricular structure in patients with asymptomatic aortic valve stenosis (a SEAS substudy) , 2010, Journal of hypertension.

[25]  E. Donal,et al.  Prognostic effect of long-axis left ventricular dysfunction and B-type natriuretic peptide levels in asymptomatic aortic stenosis. , 2010, The American journal of cardiology.

[26]  S. Umemura,et al.  Utility and feasibility of a new programmable home blood pressure monitoring device for the assessment of nighttime blood pressure , 2009, Clinical and Experimental Nephrology.

[27]  J. Schwartz,et al.  Night time blood pressure variability is a strong predictor for cardiovascular events in patients with type 2 diabetes. , 2009, American journal of hypertension.

[28]  Jan A. Staessen,et al.  Daytime and Nighttime Blood Pressure as Predictors of Death and Cause-Specific Cardiovascular Events in Hypertension , 2008, Hypertension.

[29]  Paolo Verdecchia,et al.  Impact of blood pressure variability on cardiac and cerebrovascular complications in hypertension. , 2007, American journal of hypertension.

[30]  R. Bansal,et al.  Clinical profile and natural history of 453 nonsurgically managed patients with severe aortic stenosis. , 2006, The Annals of thoracic surgery.

[31]  D. Conen,et al.  High prevalence of newly detected hypertension in hospitalized patients: the value of inhospital 24-h blood pressure measurement , 2006, Journal of hypertension.

[32]  Roberto Sega,et al.  Prognostic Value of Ambulatory and Home Blood Pressures Compared With Office Blood Pressure in the General Population: Follow-Up Results From the Pressioni Arteriose Monitorate e Loro Associazioni (PAMELA) Study , 2005, Circulation.

[33]  J. Garot,et al.  Predictors of outcome in patients with severe aortic stenosis and normal left ventricular function: role of B-type natriuretic peptide. , 2004, European heart journal.

[34]  A. Ferreira,et al.  N-Terminal–Pro-Brain Natriuretic Peptide Predicts Outcome After Hospital Discharge in Heart Failure Patients , 2004, Circulation.

[35]  H. Baumgartner,et al.  Natriuretic Peptides Predict Symptom-Free Survival and Postoperative Outcome in Severe Aortic Stenosis , 2004, Circulation.

[36]  James D. Thomas,et al.  Plasma B-type natriuretic peptide levels in systolic heart failure: importance of left ventricular diastolic function and right ventricular systolic function. , 2004, Journal of the American College of Cardiology.

[37]  B. Carabello Evaluation and management of patients with aortic stenosis. , 2002, Circulation.

[38]  G. Porenta,et al.  Predictors of outcome in severe, asymptomatic aortic stenosis , 2001 .

[39]  H. Itoh,et al.  Plasma levels of brain and atrial natriuretic peptides elevate in proportion to left ventricular end-systolic wall stress in patients with aortic stenosis. , 1997, American heart journal.